Search Results - subject:"antiviral"

Did you mean: subject:"antivirals" (45 results)

Antivirals to prepare for surges in influenza cases : an economic evaluation of baloxavir marboxil for the Netherlands

Pol, Simon van der; Postma, Maarten J.; Boersma, Cornelis - In: The European journal of health economics 25 (2024) 9, pp. 1557-1567

Persistent link: https://www.econbiz.de/10015141830

Factors affecting the recovery of Kurdistan province COVID-19 patients: a cross-sectional study from March to June 2020

Zandkarimi, Eghbal - In: Epidemiologic Methods 10 (2021) s1

. Results According to the results of this study, age, sex, coronary heart disease (CHD), cancer, and using antiviral drugs were …

Persistent link: https://www.econbiz.de/10014590680

Resource support of adaptation capabilities of the pharmaceutical industry under COVID-19 pandemic

Klunko, Natalia - In: Technology audit and production reserves 2 (2021) 4/58, pp. 6-11

Persistent link: https://www.econbiz.de/10013164162

Global Program for Avian Influenza Control and Human Pandemic Preparedness and Response: Project Accomplishments

Jonas, Olga; Warford, Lucas - Economics Research, World Bank Group - 2014

This report reviews some of the accomplishments of the Global Program for Avian Influenza Control and Human Pandemic Preparedness and Response (GPAI). This multisectoral program comprised 72 projects in 60 developing countries in all regions and received $1.3 billion in financing from the World...

Persistent link: https://www.econbiz.de/10011183010

Plant-Derived Compounds and Their Potential Role in Drug Development

Kaloudas, Dimitrios; Penchovsky, Robert - In: International Journal of Biomedical and Clinical … 7 (2018) 1, pp. 53-66

This article describes how with the development of biotechnology, plants have gained again a prominent place as a relatively inexpensive source for the creation of recombinant pharmaceuticals. Plant-derived compounds have started playing a major role in the pharmaceutical industry with many...

Persistent link: https://www.econbiz.de/10012043238

Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective

Carrasco, L R; Lee, V J; Chen, M I; Matchar, D B; … - Volkswirtschaftliche Fakultät, … - 2011

. Stockpiling antiviral drugs to manage a pandemic is an effective strategy to offset their negative impacts; however, little is …. Using an epidemic–economic model we studied the effect on total mortality and costs of antiviral stockpile sizes for Brazil … should aim to store antiviral stockpiles able to cover at least 15 per cent of their population, rising to 25 per cent with …

Persistent link: https://www.econbiz.de/10011108927

Interaction of amphipathic α-helical peptides with a lipid membrane: Adsorption and pore formation

Zhdanov, Vladimir P. - In: Physica A: Statistical Mechanics and its Applications 401 (2014) C, pp. 45-51

Amphipathic α-helical peptides often exhibit antimicrobial or antiviral properties. Adsorption of such peptides at a …

Persistent link: https://www.econbiz.de/10011063763

Factors associated with physicians' prescribing behavior for treatment of influenza in the USA

Patel-Dovlatabadi, Payal - In: International Journal of Pharmaceutical and Healthcare … 8 (2014) 1, pp. 27-46

examine why the number of antiviral prescriptions remains substandard. Design/methodology/approach – Data were obtained from … physicians, 40.5 percent prescribed antiviral medications to patients presenting with influenza while 59.5 percent prescribed … associated with physicians' prescribing practices of antiviral medications, a more timely diagnosis and treatment of influenza …

Persistent link: https://www.econbiz.de/10014795923

Factors associated with physicians' prescribing behavior for treatment of influenza in the USA

Patel-Dovlatabadi, Payal - In: International journal of pharmaceutical and healthcare … 8 (2014) 1, pp. 27-46

Persistent link: https://www.econbiz.de/10010365486

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country

Toy, Mehlika; Onder, Fatih; Idilman, Ramazan; Kabacam, … - In: The European Journal of Health Economics 13 (2012) 5, pp. 663-676

In a country with considerable amount of active CHB patients, monotherapy with a highly potent third generation drug has the most health-gain, and is cost-effective in both HBeAg-positive and negative in all stages of liver disease. </AbstractSection> Copyright The Author(s) 2012

Persistent link: https://www.econbiz.de/10010993910